Clinical Trial Details
EORTC-30884
Back to Clinical Trials Database
Phase II protocol for the study of high dose Epirubicin in patients with progressive measurable metastatic prostate cancer
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 15-Apr-1989 Date Step1 close: 01-Jul-1992 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 23 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number |
